✦ LIBER ✦

232 Cisplatin, ifosfamide and vinorelbine with granulocyte colony-stimulating factor (G-CSF) as a treatment of advanced non small cell lung cancer (NSCLC). Preliminary results of a phase II study

✍ Scribed by Pronzato, P.; Ghio, E.; Pensa, F.; Stagnaro, A.; Vaira, F.; Vigani, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of irinotecan and infus

✍ Mori, K.; Machida, S.; Yoshida, T.; Noda, M.; Tominaga, K. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Phase I study of etoposide in combinatio

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 167 KB

69 Paclitaxel (TAX), ifosfamide (IFX), a

✍ Masters, G.; Hoffman, P.; Samuels, B.; Mauer, A.; Krauss, S.; Golomb, H.; Vokes, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Combination of gemcitabine (G), ifosfami

✍ Castellano, D; Lianes, P; Arcediano, A; García-Carbonero, R; Paz-Ares, L; Cortés 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 130 KB

A phase II study of irinotecan and infus

✍ Kiyoshi Mori; Suguru Machida; Takeshi Yoshida; Munehide Yoshida; Yasuliko Kano; 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 68 KB

128 Preliminary results of a phase II st

✍ Pérol, M.; Souquet, P.J.; Riou, R.; Fournel, P.; Dussopt, C.; Vuillermoz, S.; Bo 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 290 KB